PMID- 33927085 OWN - NLM STAT- MEDLINE DCOM- 20211125 LR - 20230821 IS - 1538-943X (Electronic) IS - 1058-2916 (Print) IS - 1058-2916 (Linking) VI - 67 IP - 10 DP - 2021 Oct 1 TI - The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device Implantation. PG - 1159-1162 LID - 10.1097/MAT.0000000000001378 [doi] AB - Left ventricular assist devices (LVADs) improve quality of life (QoL) and functional capacity (FC) for patients with advanced heart failure. The association between adverse events (AEs) and changes in QoL and FC are unknown. Patients treated with the HeartWare ventricular assist device (HVAD) with paired 6-minute walk distance (6MWD, n = 263) and Kansas City Cardiomyopathy Questionnaires (KCCQ, n = 272) at baseline and 24 months in the ENDURANCE and ENDURANCE Supplemental Trial databases were included. Patients were stratified based upon occurrence of clinically significant AEs during the first 24 months of support and analyzed for the mean change in 6MWD and KCCQ. The impact of AE frequency on change in 6MWD and KCCQ from baseline to 24 months was evaluated. Of the AEs examined, only sepsis was associated with an improvement in 6MWD (109 m vs. 16 m, p = 0.002). Patients without improvement in 6MWD test from baseline to 24 months had significantly more AEs than those with FC improvement (p = 0.0002). Adverse events did not affect the KCCQ overall summary score. In this analysis, patients with fewer AEs had greater improvement in FC during the 24-month follow up. The frequency of AEs did not have a significant impact on QoL after LVAD implantation. CI - Copyright (c) ASAIO 2021. FAU - Samsky, Marc D AU - Samsky MD AD - From the Duke University Medical Center, Durham, North Carolina. FAU - Milano, Carmelo A AU - Milano CA AD - From the Duke University Medical Center, Durham, North Carolina. FAU - Pamboukian, Salpy AU - Pamboukian S AD - University of Alabama at Birmingham, Birmingham, Alabama. FAU - Slaughter, Mark S AU - Slaughter MS AD - University of Louisville, Louisville, Kentucky. FAU - Birks, Emma AU - Birks E AD - University of Louisville, Louisville, Kentucky. FAU - Boyce, Steven AU - Boyce S AD - Washington Hospital Center, Washington, DC. FAU - Najjar, Samer S AU - Najjar SS AD - MedStar Washington Hospital Center, Washington, DC. FAU - Itoh, Akinobu AU - Itoh A AD - Washington University, St Louis, Missouri. FAU - Reid, Bruce AU - Reid B AD - Intermountain Medical Center, Murray, Utah. FAU - Mokadam, Nahush AU - Mokadam N AD - University of Washington, Seattle, Washington. FAU - Aaronson, Keith D AU - Aaronson KD AD - University of Michigan, Ann Arbor, Michigan. FAU - Pagani, Francis D AU - Pagani FD AD - University of Michigan, Ann Arbor, Michigan. FAU - Rogers, Joseph G AU - Rogers JG AD - From the Duke University Medical Center, Durham, North Carolina. LA - eng GR - T32 HL069749/HL/NHLBI NIH HHS/United States PT - Journal Article PL - United States TA - ASAIO J JT - ASAIO journal (American Society for Artificial Internal Organs : 1992) JID - 9204109 SB - IM MH - *Heart Failure/surgery MH - *Heart-Assist Devices/adverse effects MH - Humans MH - Quality of Life MH - Treatment Outcome MH - Walking PMC - PMC8478694 MID - NIHMS1656617 COIS- Disclosure: M.D.S. received salary supported from NIH T32 training grant (HL069749). M.S.S. received research grant funding from Heartware/Medtronic. N.M. has served as a consultant to Abbott, Medtronic, SynCardia, and Carmat. The other authors have no conflicts of interest to report. EDAT- 2021/05/01 06:00 MHDA- 2021/11/26 06:00 PMCR- 2022/10/01 CRDT- 2021/04/30 06:12 PHST- 2021/05/01 06:00 [pubmed] PHST- 2021/11/26 06:00 [medline] PHST- 2021/04/30 06:12 [entrez] PHST- 2022/10/01 00:00 [pmc-release] AID - 00002480-202110000-00013 [pii] AID - 10.1097/MAT.0000000000001378 [doi] PST - ppublish SO - ASAIO J. 2021 Oct 1;67(10):1159-1162. doi: 10.1097/MAT.0000000000001378.